Wells Fargo & Company Stoke Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,104 shares of STOK stock, worth $122,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,104
Previous 11,387 2.49%
Holding current value
$122,810
Previous $153,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$12.24 - $15.92 $3,463 - $4,505
-283 Reduced 2.49%
11,104 $136,000
Q2 2024

Aug 13, 2024
BUY
$11.03 - $17.52 $16,931 - $26,893
1,535 Added 15.58%
11,387 $153,000
Q1 2024

May 10, 2024
BUY
$4.12 - $14.17 $5,570 - $19,157
1,352 Added 15.91%
9,852 $133,000
Q4 2023

Feb 09, 2024
BUY
$3.37 - $5.4 $5,668 - $9,082
1,682 Added 24.67%
8,500 $44,000
Q3 2023

Nov 13, 2023
SELL
$3.78 - $11.99 $13,944 - $44,231
-3,689 Reduced 35.11%
6,818 $26,000
Q2 2023

Aug 15, 2023
BUY
$7.93 - $13.82 $51,671 - $90,051
6,516 Added 163.27%
10,507 $111,000
Q1 2023

May 12, 2023
BUY
$7.65 - $10.38 $29,766 - $40,388
3,891 Added 3891.0%
3,991 $33,000
Q4 2022

Feb 13, 2023
SELL
$7.07 - $15.69 $1,725 - $3,828
-244 Reduced 70.93%
100 $0
Q3 2022

Nov 14, 2022
SELL
$12.56 - $22.53 $2,901 - $5,204
-231 Reduced 40.17%
344 $5,000
Q2 2022

Aug 12, 2022
SELL
$10.36 - $23.93 $10,152 - $23,451
-980 Reduced 63.02%
575 $8,000
Q1 2022

May 16, 2022
SELL
$17.19 - $26.1 $111,494 - $169,284
-6,486 Reduced 80.66%
1,555 $33,000
Q4 2021

Feb 14, 2022
SELL
$18.11 - $30.72 $54,945 - $93,204
-3,034 Reduced 27.4%
8,041 $193,000
Q3 2021

Nov 15, 2021
BUY
$23.65 - $34.44 $142,987 - $208,224
6,046 Added 120.22%
11,075 $282,000
Q2 2021

Aug 16, 2021
SELL
$30.53 - $41.09 $194,995 - $262,441
-6,387 Reduced 55.95%
5,029 $169,000
Q1 2021

May 13, 2021
BUY
$36.08 - $69.81 $122,166 - $236,376
3,386 Added 42.17%
11,416 $444,000
Q4 2020

Feb 09, 2021
BUY
$33.62 - $61.93 $78,334 - $144,296
2,330 Added 40.88%
8,030 $497,000
Q3 2020

Nov 05, 2020
SELL
$22.23 - $37.48 $101,613 - $171,321
-4,571 Reduced 44.5%
5,700 $191,000
Q2 2020

Aug 13, 2020
SELL
$20.26 - $29.73 $221,624 - $325,216
-10,939 Reduced 51.57%
10,271 $245,000
Q1 2020

May 14, 2020
BUY
$16.8 - $34.15 $356,328 - $724,321
21,210 New
21,210 $486,000

Others Institutions Holding STOK

# of Institutions
124
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $436M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email